The aim of this study was to examine the impact of CYP2C19 genotype on clinical outcome in coronary artery disease (CAD) patients with or without diabetes mellitus (DM).CYP2C19 polymorphism and DM are associated with increased risk of cardiovascular events during antiplatelet therapy following stent implantation. Platelet reactivity during clopidogrel therapy and CYP2C19 polymorphism were measured in 519 CAD patients (males 70
作者:Michio, Mizobe;Seiji, Hokimoto;Tomonori, Akasaka;Yuichiro, Arima;Koichi, Kaikita;Kazunori, Morita;Hiroko, Miyazaki;Kentaro, Oniki;Kazuko, Nakagawa;Hisao, Ogawa
来源:Thrombosis research 2014 年 134卷 1期